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Abstract The acid–base properties and the Cu(II) bind-
ing processes of methotrexate (MTX) were characterized
by selected spectroscopic techniques and potentiometric
measurements. The pH titration data showed that MTX
behaves as a triprotic ligand. The deprotonation constants
were determined for a-COOH and c-COOH groups and
(N1)H? from the pteridine ring. Taking all the obtained
results into consideration, a coordination pattern was pro-
posed. The DNA-cleaving activity and reactive oxygen
species (ROS) generation were investigated for both MTX
and the Cu(II)–MTX system. The complex displayed a
promising nuclease activity toward plasmid DNA in the
presence of hydrogen peroxide. Interestingly, the induction
of ROS, such as hydroxyl radicals, superoxide anions or
singlet oxygen, was excluded and a different mechanism of
DNA degradation was proposed. As MTX is now com-
monly used in anticancer therapy i.e. against lung cancer,
basic cell-based studies were carried out to establish if its
Cu(II) complex exhibits higher cytotoxic properties than
the ligand alone. Activities of both compounds were also
tested against colon carcinoma. Moreover, the determined
values of IC50 were confronted with the cytotoxic activity
of cisplatin.
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is a folic acid antagonist and it has a therapeutic effect on
many types of cancer cells. It is currently widely used as a
major chemotherapeutic agent for human malignancies,
such as acute lymphoblastic leukemia, lymphoma, osteo-
sarcoma, and also breast, lung, head, and neck cancers
(Yoon et al., 2010). In the body, MTX is taken up by cells
and tissues and then immediately metabolized to polyglu-
tamate derivatives. Polyglutamates block the synthesis of
purines and pyrimidines by inhibiting dihydrofolate
reductase and several other folate-dependent enzymes. This
blocking results in the disruption of DNA biosynthesis and
is the basis of MTX chemotherapeutic action (Chibber
et al., 2012). Tumor cells require about tenfold higher
concentration of thymidine triphospate than healthy cells,
and therefore they are more sensitive to the effects of
antifolates (Navarro-Peran et al., 2005).
MTX is a methylated derivative of folic acid (Fig. 1).
Its structure consists of a pteridine ring and dimethyl-p-
aminobenzoic acid residue linked with glutamic acid.
The coordination properties of this compound are not
well characterized. Metal complexes of pteridines are
rare since it is a highly p electron-deficient heterocyclic
system (Kaim et al., 1999). On the other hand, the
binding properties of glutamic acid, which forms ther-
modynamically stable complexes with a number of metal
ions, are well characterized (Sajadi, 2010; Naik et al.,
2012).
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Copper is an important metal ion and an essential con-
stituent of our biological enzyme systems. It is proven that
both in inflammatory conditions and during neoplastic
diseases copper plasma concentration rises from 15 lM/L
in normal to 22–26 lM/L in cancerous cells (Zowczak
et al., 2001). Hence, it is possible that chemotherapeutic
drugs have an opportunity to interact with endogenous
copper. Therefore, the aim of this work was to: (1) inves-
tigate the coordination properties of MTX toward Cu(II)
ions, (2) verify the ability of this complex to generate ROS
and DNA damage, and (3) establish the potential cytotoxic




Methotrexate, CuCl2 9 6H2O, TSP-d4 (trimethylsilyl pro-
pionate), D2O, DNO3, NaOD, and pUC18 plasmid DNA
were obtained from Sigma-Aldrich Co, Germany. NaOH,
HCl, and ethylene glycol were purchased from Merck
KGaA, Germany. Calibration buffers at pH values 4.01 and
9.21 was received from Mettler-Toledo GmbH, Germany.
Potentiometric measurements
Potentiometric titrations of MTX and its complexes with
Cu(II) in aqueous solution in the presence of 0.1 M KCl
were performed at 298 K under argon atmosphere using
pH-metric titrations (Metrohm, 905 Titrando). The CO2
free NaOH solution was used as a titrant. The samples were
titrated in the pH region 2.0–10.5 using a total volume of
1.5 mL. Changes in pH were monitored with a combined
glass–Ag/AgCl electrode (Metrohm, Biotrode) calibrated
daily by HCl titrations (Irving et al., 1967). Ligand con-
centration was 5 9 10-4 M, and metal to ligand molar
ratios of 1:1 and 1:4 were used. These data were analyzed
using the SUPERQUAD program (Gans 1983). Standard
deviations (r values) quoted were computed by SUPER-
QUAD and refer to random errors.
Nuclear magnetic resonance (NMR)
1H NMR and 13C NMR measurements were performed on
a Bruker AMX-500 instrument (1H: 500 MHz). TSP (tri-
methylsilyl propanoic acid) was used as an internal stan-
dard. Samples were prepared in 500 ll D2O (99.95 %) and
the final concentration was 10 mM and 40 mM for proton
and carbon spectra, respectively. NMR spectra were
recorded for MTX and Cu(II)–MTX system at pD (pH
measured by electrode uncorrected for the isotopic effect)
value 7.5, which after appropriate correction (Krę _zel and
Bal, 2004) is equal to 7.4. Measurements were made for
solutions at five different Cu(II)–MTX molar ratios 1:500
7 5:500. The pD of samples was adjusted by adding small
volumes of concentrated DNO3 or NaOD.
Infrared spectroscopy (IR)
The room temperature infrared powder spectra were
recorded using Bruker IFS-66 FT spectrometer. The scan-
ning range was 4,000–400 cm-1 and the resolution was
2 cm-1. Spectra of MTX alone and the Cu(II)–MTX
complex were registered in a transmission mode as KBr
pellets.
DNA strand break analysis
The ability of Cu(II)–MTX complex to induce single- and/
or double-strand breaks in the absence or presence of H2O2
was tested with the pUC18 plasmid on 1 % agarose gels
containing ethidium bromide. The buffered samples
(phosphate buffer, pH 7.4) contained combinations of DNA
(25 lg/mL) and the components of investigated systems
(metal ion and/or antibiotic, H2O2). Concentrations of each
substance are given in figure captions. The metal to ligand
molar ratio 1:1 was used according to the complexes
stoichiometry based on the potentiometric calculations.
After 1 h of incubation at 37 C in the dark, the reaction
mixtures were mixed with 4 mL of loading buffer (bro-
mophenol blue in 30 % glycerol) and loaded on 1 % aga-
rose gels containing ethidium bromide (Sigma-Aldrich), in
TBE buffer (90 mM Tris–borate, pH 8.0; 20 mM EDTA).
Gel electrophoresis was done at a constant voltage of
4 V/cm for 60 min. As a control for double-strand breaks,
reference plasmid samples were linearized with EcoRI
endonuclease. The gels were photographed and processed
with a Digital Imaging System (Syngen Biotech, Wroclaw,
Poland).
Fig. 1 The molecular formula of MTX with atom numeration
scheme used for 13C NMR spectra analysis
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Reactive oxygen species (ROS) generation
measurements
The ROS generation measurements were carried out with
NDMA (N,N-dimethyl-4-nitrosoaniline) and NBT (nitro-
tetrazolium blue chloride), a scavenger molecules com-
monly used in studies of hydroxyl radicals and superoxide
anion generation, respectively. The experiments were fol-
lowed at 25 C on a Cary 60 spectrophotometer. The
solutions of NDMA and NBT at final concentrations
20 lM were added to the samples containing 50 lM
Cu(II), MTX and Cu(II)–MTX, in the presence of 50 lM
H2O2, at pH 7.4 (0.2 M phosphate buffer). The generation
of singlet oxygen was tested by gel electrophoresis in
conditions described above (‘‘DNA strand break analysis’’
section) with an extra addition of NaN3 (singlet oxygen
scavenger (Franco et al., 2007)) at final concentration
40 mM.
Cytotoxic assay
Cell lines and culture conditions
CT26 cell line (mouse colon carcinoma, morphology:
fibroblast, ATCC: CRL–2638) and A549 cell line (human
lung adenocarcinoma, morphology: epithelial, ATCC:
CCL–185) were obtained from professor Luis G. Arnaut
group (Chemistry Department, University of Coimbra,
Portugal). Cells were cultured in flasks in Dulbecco’s
Modified Eagle Medium (DMEM) without phenol red,
with 10 % fetal bovine serum (FBS) and with 1 % strep-
tomycin/penicillin at 37 C and 5 % CO2 in a humidified
atmosphere. Cells were passaged at preconfluent densities,
using a solution containing 0.05 % trypsin and 0.5 mM
EDTA. All the cell culture fluids were purchased from
IMMUNIQ (Poland).
Cytotoxicity study
The cytotoxic activity in vitro was evaluated by the MTT
assay. The assay was carried out according to the well-
known protocol (Slater et al., 1963). For the screening
experiments, exponentially growing cells were harvested
and plated in 96–well plates at a concentration of 1 9 104
cells/well. After 24 h of incubation at 37 C under
humidified 5 % CO2 allowing cell attachment, the cells in
the wells were treated with tested compounds at various
concentrations in the range from 1 to 100 lM. The com-
pounds were predissolved in phosphate buffer (pH 7.4) and
diluted in the respective medium with 1 % FBS.
Two different protocols of cytotoxicity evaluation were
performed. In the first approach cells were treated with
200 lL of tested samples: CuCl2, MTX, Cu(II)–MTX, and
cisplatin for 4 h at 37 C under conditions of 5 % CO2.
Then, solutions were removed, cells were washed with PBS
(phosphate buffered saline, IMMUNIQ, Poland) and fresh
relevant medium was added. Cells were incubated for 24 h
at standard conditions and then cytotoxicity was estimated
once more. Whereas, in the second approach cells were
incubated with various concentrations of tested samples
diluted in DMEM containing 1 % FBS for 24 h in standard
conditions. After that time surviving fraction was deter-
mined by MTT assay.
MTT assay
Briefly, a solution of 3–(4,5–dimethylthiazo1–2–y1)–2,5–
diphenyltetrazolium bromide (MTT, Sigma) was prepared
at 5 mg/mL in PBS and was diluted 1:10 in DMEM
without FBS. 200 lL of this solution was added to each
well. After 4 h of incubation at 37 C in a humidified
incubator with 5 % CO2, the medium/MTT mixtures were
removed, and the formazan crystals formed by the mito-
chondrial dehydrogenase activity of vital cells were dis-
solved in 100 lL of DMSO:CH3OH dilution (1:1). The
absorbance of soluble product was read with a microplate
reader (Infinite 200 M PRO NanoQuant, Tecan, Switzer-
land) at 565 nm.
Data analysis
Cell viability was calculated using cells treated with
DMEM containing 1 % FBS as control. Cell surviving
fraction (%) was calculated using the formula: S/S0
(%) = [abs565nm of treated cells/abs565nm of untreated
cells (control)] 9 100. Each experiment was done in
triplicate and was repeated at least twice. The inhibitory
concentration (IC) values were calculated from a dose–
response curve. IC50 values were determined from the
fitting curve by calculating the concentration of agent that
reduced the surviving fraction of treated cells by 50 %,
compared to control cells. IC50 data are expressed as
mean values ± standard deviation (SD) and they are the
average of two independent experiments, done in
triplicate.
Fluorescence microscopy
Viable and dead cells were detected by staining with AO
(5 mg/L) and PI (5 mg/L) for 20 min and examined using
fluorescence- inverted microscope (Olympus IX51, Japan)
with an excitation filter of 470/20 nm. Photographs of the
cells after treatment with the tested compounds were taken
under magnification 20.009.
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Results and discussion
The acid–base chemistry of methotrexate
MTX molecule contains a 2,4-diaminopteridine ring and
N,N-dimethyl-p-aminobenzoic acid residue linked with
glutamic acid by a peptide bond (Fig. 1). It exists in water
solution in a fully protonated form as a H3L ligand. The
acid–base properties of the moieties, which can be depro-
tonated with a rise of pH value, were determined using
potentiometric measurements (Table 1). The first two
obtained pKa values: 2.89 and 4.56 correspond to the
deprotonation of carboxylic groups from glutamic acid,
a-COOH and c-COOH, respectively (Poe, 1973, 1977;
Meloun et al., 2010). The highest value of pKa = 5.65
corresponds to the deprotonation process of the heterocy-
clic nitrogen (N1)H? from the pteridine ring. The resulting
pKa values are quite consistent with the literature data.
They have been first determined by Poe (1973) using
potentiometric and spectrophotometric titrations, as 3.36,
4.70, and 5.71, respectively.
Investigation of the Cu(II)–methotrexate coordination
mode
In order to obtain insight into the binding mode of MTX,
the complex formation processes were studied by potenti-
ometry, IR, and NMR spectroscopic techniques. These
methods all together enabled verification of the type of
donor atoms bound to Cu(II) ions and determination of the
stability constants (Table 1). In the investigated pH range
three monomeric complexes are formed: CuHL, CuL, and
CuH-1L. Stability constants for bis-ligand complexes
could not be established with certainty, therefore they were
excluded from the accepted model. The binding process
starts at pH 3.0 with the appearance of a CuHL form, as
shown in the distribution diagram (Fig. 2). Considering the
acid–base properties of the ligand, it is clear that in the
presence of copper(II) ion the MTX molecule simulta-
neously loses two protons. The groups with the lowest pKa
values are the a-carboxyl and c-carboxyl ones. It can be
assumed that the Cu(II) ion binds to the oxygen atoms from
both of them. With the rise of pH, the species distribution
diagram reveals the occurrence of a new CuL form which
reaches the maximum concentration at pH * 5.8. In that
pH range deprotonation of (N1)H? nitrogen takes place
probably without its participation in the binding process.
The last species, CuH-1L, is formed due to the forced
dissociation of amide moiety caused by metal ion binding
to this fragment of the studied molecule.
These assumptions are supported by the NMR and IR
results. Using NMR spectroscopy we could verify the type
of donor atoms bound to the metal ion in solution. As in a
number of other instances (Bertini and Pierattelli, 2004;
Otting, 2010), also in this case the coordination of the
paramagnetic cation causes a significant decrease of the
intensity or even disappearance of the signals derived from
the neighboring carbon atoms. Thus, the interaction of
MTX with small amounts of Cu(II) solution (M:L 1:500)
also results in vanishing of both carboxylic carbons and Ca
signals from glutamyl residue (Fig. 3). The remaining
peaks from glutamic carbon atoms and the neighboring
CC=O have a lower intensity. These findings support the
model of coordination {a-COO-, c-COO-, and Namide}
deduced above (Fig. 4). The chemical shift values of MTX
carbon atoms are collected in Table 2.
Interestingly, the intensity of all 13C NMR signals from
the pteridine ring also slightly decreases. The participation
of this part of the molecule in the binding process does not
fit the expected model. There could be one explanation for
this phenomenon connected with the stacking interaction.
The self-association of heterocyclic aromatic compounds




H3L 13.10 (4) 2.89
H2L 10.21 (3) 4.56
HL 5.65 (3) 5.65
CuHL 8.82 (6) –
CuL 4.01 (3) 4.81
CuH-1L -2.32 (3) 6.33
a nH??Lm- $ HnL, statistical errors on the last digits of stability
constant are given in parentheses. Overall stability constant (b)
expressed by equation bHnL = [HnL
(m–n)-]/[H?][Lm-] describes a
reaction
b Deprotonation constant (pKa) expressed by equation pKa = logb
(HnL
(m–n)-) - logb (Hn-1 L
(m–n?1)-)
Fig. 2 Species distribution diagram for the Cu(II)–MTX system
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has been observed for purines and pyrimidines, structurally
related to MTX (Sigel and Griesser, 2005; Mitchell and
Sigel, 1978; Dunger et al., 1998). Therefore, this process
can be expected in the studied case. MTX is known to
aggregate, depending on the concentration and pH. How-
ever, the investigation of folates showed that these com-
pounds do not form higher oligomers than dimers (Poe,
1973). According to this knowledge, at the neutral pH an
MTX dimer consists of two molecules in a fully ‘‘stretched
out’’ configuration. Consequently, both pteridine and
p-aminobenzoate rings may participate in stacking inter-
actions in a head-to-tail arrangement (Poe, 1973). This
circumstance would be very helpful in the explanation of
the disappearance of 13C NMR signals from pteridine
moiety in the course of the present research. Chemical
shifts are very sensitive to the environment. Looking at the
proposed dimer structure, it is clearly seen that the pteri-
dine ring is localized exactly above the p-aminobenzoate
ring linked with glutamic acid (Fig. 5). Therefore, binding
of copper(II) ions to carboxyl groups and amide nitrogen
reduces the intensity of the signals of both the adjacent
carbon atoms and pteridinic atoms.
The results obtained from FTIR experiments also sup-
port the proposed coordination mode. When comparing the
solid state spectra of MTX and the Cu(II)–MTX system
(Fig. S1), the most pronounced changes were recorded in
the range of asymmetric stretching vibrations of COO-
groups (1700–1600 cm-1). These bands are not visible in
the complex spectrum. Returning to the analysis of the
ligand data, it is supposed that MTX exists in a zwitterionic
Fig. 3 13CNMR spectra of
MTX and Cu(II)–MTX
solutions at pH 7.4
Fig. 4 The model of Cu(II)–
MTX complex existing at
pH 7.5
Med Chem Res (2015) 24:115–123 119
123
form with a positive charge at two pteridine amino groups
and a negative charge at carboxylate anions. An absorption
band above 1700 cm-1 characteristic for the COOH group
was not observed. However, there is a band in the range of
1690–1640 cm-1 which corresponds to the asymmetric
stretching vibration of the COO- moieties. Simulta-
neously, the band originating from the amino group
vibrations does not appear. Instead, overlapped bands can
be seen derived from the stretch vibration of carboxylate
anions and asymmetric deformation of –NH3
?. Such
zwitterionic structure can facilitate the coordination of
positive copper ion to the negative carboxylates.
DNA damage and ROS generation by the Cu(II)–MTX
system
In order to investigate the nuclease activity of the cop-
per(II) complexes with MTX, pUC18 plasmid was used as
the DNA substrate, and the resulting products were
analyzed by an agarose-gel electrophoresis method. The
cleavage activity was determined by measuring the con-
version of supercoiled plasmid DNA (form I) to open-cir-
cular DNA (form II) or linear DNA (form III). The initial
experiments show that the studied drug neither alone
(Fig. 6, lanes 3, 9) nor in the presence of hydrogen per-
oxide (lanes 6, 12) is able to damage the DNA, regardless
of the ligand concentration. Although Cu(II) ions alone
(lanes 2, 8) and complexed (lanes 4, 10) yield some
increase in the open-circular form II, significant changes in
the plasmid structure are observed in the presence of H2O2
(lanes 5, 7, 11, 13). The obtained results demonstrate that
complex-H2O2 (lanes 11 and 13) is the most efficient in
plasmid degradation. As shown in Fig. 7, the Cu(II)–MTX-
H2O2 system causes the cleavage of supercoiled DNA to its
open-circular (II) and linear (III) form in a wide concen-
tration range (from 5 lM to 1 mM). Moreover, these
effects are accompanied by cutting the plasmid into shorter
polynucleotide fragments, which is particularly evident on
lanes 7 and 9. The quantity of the form II is in these cases
negligible and streaks are the most visible. At a twice lower
concentration of hydrogen peroxide, the plasmid destruc-
tion process is identical.
In order to gain some insight into the mechanism by
which the complex-H2O2 system induces DNA cleavage,
the ability to generate ROS was investigated. Most of the
studied Cu(II) complexes have caused single- and double-
strand DNA scissions by the oxidative mechanism in the
presence of endogenous amounts of hydrogen peroxide
(Suntharalingam et al., 2012; de Hoog et al., 2007;
Devereux et al., 2007; Szczepanik et al., 2002; Je _zowska-
Bojczuk et al., 2002). It has often been evident that the
presence of an antibiotic enhanced the oxidative activity of
Cu(II) ions, and the resulting complex exhibited much
higher potency toward ROS induction (Gaggelli et al.,
2010; Balenci et al., 2009). The hydroxyl radicals detection
is performed by monitoring the NDMA characteristic band
at 440 nm on the electronic spectra. Generation of thė OH
radicals causes the decrease in the intensity of this band
and can be measured in a time-dependent mode. The˙OH
induction by the complex-H2O2 system was investigated in
the conditions of gel electrophoresis experiments (50 lM
concentration of both the complex and H2O2). However,
only a slight decrease of the NDMA band was observed.
The ability to generate superoxide anion by the complex-
H2O2 system was also examined by performing a similar
test with another reporter molecule-NBT. Likewise, the
investigated system failed to induce this type of radicals.
The next experiment was carried out using gel electro-
phoresis by adding sodium azide (singlet oxygen scaven-
ger) to the reaction mixture. This procedure did not cause
the inhibition of the cleavage reaction either.
Table 2 The 13C NMR chemical shifts for MTX solution at pH 7.4
Carbon d [ppm] Carbon d [ppm]
C1 182.3 C10 128.8
C2 179.2 C11 122.2
C3 169.3 C12 120.6
C4 162.9 C13 111.7
C5 161.7 C14 55.8
C6 152.9 C15 54.9
C7 151.7 C16 38.6
C8 149.2 C17 34.3
C9 148.3 C18 28.6
Assignments were made on the basis of Spectrum Database of
Organic Compounds
Fig. 5 Proposed structure for MTX dimer on the basis of crystal data
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Taken together, the obtained results suggest that the
single- and double-stranded DNA cleavage mediated by
complex-H2O2, does not occur by an oxidative mechanism.
On the other hand, the same reactions performed without
hydrogen peroxide do not result in plasmid degradation
(Fig. 6, lanes 4, 10). This led us to propose that most
probably the active species is copper-oxene or copper-
coordinated hydroxyl radical (Sigman et al., 1991; Baron
et al., 1936). The reactive species remain tightly bound to
copper(II), thus preventing them from being deactivated by
radical scavengers. A copper-oxene or a resonance hybrid
of a copper(II)-hydroxyl radical species generates a
deoxyribose-centered radical by C-1 hydrogen abstraction
(Sigman et al., 1991; Baron et al., 1936), and is probably
responsible for plasmid DNA cleavage in the studied case.
In vitro cytotoxic studies
The anticancer activity of MTX, CuCl2, Cu(II)–MTX, and
cisplatin against two selected cell lines: mouse colon car-
cinoma (CT26) and human lung adenocarcinoma (A549)
were investigated. The evaluation of the cytotoxic activity
of the compounds was carried out by the MTT assay, based
on the ability of mitochondrial dehydrogenases in the
viable cells to cleave the tetrazolium rings of MTT and to
form dark blue membrane-impermeable crystals of for-
mazan. The surviving fraction was determined by the
relationship between the optical absorbance of dissolved
formazan into a colored solution and the number of viable
cell.
The IC50 values were derived from dose–response
curves and are summarized in Table 3. Cytotoxic study
in vitro revealed that Cu(II)–MTX exhibits considerable
toxicity toward both tested cell lines. The IC50 values
obtained for the complex were in most cases lower than
those for MTX and CuCl2. Generally, the greatest effect
was observed on both cell lines after 4 h of incubation with
the tested samples (Table 3). While after 24 h the impact
Fig. 6 Agarose gel electrophoresis of pUC18 plasmid cleavage by
MTX, CuCl2, and Cu(II)–MTX (1:1). Lane 1—untreated plasmid,
lane 2—100 lM CuCl2, lane 3—100 lM MTX, lane 4—100 lM
Cu(II)–MTX, lane 5—100 lM CuCl2 ? 50 lM H2O2, lane 6—
100 lM MTX ? 50 lM H2O2, lane 7—100 lM Cu(II)–
MTX ? 50 lM H2O2, lane 8—50 lM CuCl2, lane 9—50 lM
MTX, lane 10—50 lM Cu(II)–MTX, lane 11—50 lM
Cu(II) ? 50 lM H2O2, lane 12—50 lM MTX ? 50 lM H2O2, lane
13—50 lM Cu(II)–MTX ? 50 lM H2O2
Fig. 7 Agarose gel electrophoresis of pUC18 plasmid cleavage by
Cu(II)–MTX (1:1) in the presence of 50 lM H2O2. Lane 1—untreated
plasmid; Even lanes: ? CuCl2 in concentrations: 1 mM, 500 lM,
100 lM, 50 lM, 25 lM, 5 lM; Odd lanes: ? Cu(II)–MTX at the
same, appropriate concentrations
Table 3 IC50 values for MTX, CuCl2, Cu(II)–MTX, and cisplatin
against CT26 and A549 cell lines after 4 and 24 h of incubation
IC50 values [lM]
a
4 h 24 h
CT26 A549 CT26 A549
MTX 258 ± 78 348 ± 32 460 ± 23 485 ± 12
CuCl2 360 ± 52 459 ± 32 423 ± 32 481 ± 11
Cu(II)–MTX 135 ± 17 151 ± 12 1022 ± 172 188 ± 52
Cisplatin 2200 ± 20 3150 ± 450 4990 ± 670 3850 ± 430
IC50 = concentration of drug required to inhibit growth of 50 % of
the cancer cells (Strohfeldt et al., 2008)
a Data are mean ± SD of three replicates each
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of the complex on A549 line was similar (IC50: 188 lM),
in the case of CT26 line the cytotoxic effect was dramat-
ically lower (IC50: 1022 lM). These results indicate that
A459 line is more sensitive for Cu(II)–MTX than CT26
cell line. It is noteworthy that all the tested compounds
showed a significantly better anticancer activity than cis-
platin (Table 3). Selected photographs of CT26 and A549
cell lines treated with the tested compounds are provided in
Fig. 8. Cell viability was examined by counting the dead
and alive cells stained with two fluorescent dyes. Accord-
ingly, green cells with normal nuclei were treated as viable
cells (AO?), while the red ones as dead (PI?). As can be
noticed, Cu(II)–MTX caused a significant reduction only in
the surviving fraction of A549 cell line (after 24 h of
incubation time). This means that the investigated complex
may exhibit selective biological activity toward only spe-
cific tumors. These studies indicate that Cu(II)–MTX
exhibits biological activity toward specific cell lines and
the cytotoxicity level is time dependent. The obtained
results are preliminary and further investigations are
needed to understand the molecular mechanism of
cytotoxicity.
Conclusions
It was demonstrated that MTX interacts with Cu(II) ions
and in aqueous solution it forms three monomeric com-
plexes in a wide pH range. Moreover, basic biological
in vitro studies were performed. In the presence of
hydrogen peroxide the Cu(II)–MTX system displays
nuclease activity, almost completely cleaving DNA. Most
probably, the responsibility for the plasmid degradation
processes may be attributed to the copper-oxene or copper-
coordinated hydroxyl radical. Investigations of the anti-
cancer activity showed that the complex generally displays
higher cytotoxicity in vitro than the ligand and metal ion
separately and is more selective against A459 cell line. As
MTX is used in the treatment of lung cancer, our investi-
gations demonstrated that complexation of MTX by Cu(II)
ions results in its higher cytotoxicity. Moreover, in com-
parison to cisplatin, the Cu(II)–MTX system shows supe-
rior anti-tumor effects. MTX interacts with copper(II) ions
forming complexes which display high DNA-cleaving
propensity and promising cytotoxicity. The results pre-
sented herein can be helpful in the search for new cytostatic
substances.
Acknowledgments The research was supported by the Wroclaw
Research Center EIT? under the Project ‘‘Biotechnologies and
advanced medical technologies – BioMed’’ (POIG 01.01.02-02-003/
08-00) financed from the European Regional Development Fund
(Operational Programme Innovative Economy, 1.1.2). The cytotoxic
investigations were carried out with the equipment purchased, thanks
to the financial support of the European Regional Development Fund
in the framework of the Polish Innovation Economy Operational
Program (Contract No. POIG.02.01.00-12-023/08).
Conflict of interest The authors declare that they have no conflict
of interest.
Fig. 8 The selected photos
(magnification 920.00, bar
50 lm) of CT26 and A549cells
after treated with the tested
compounds (0.05 mM) for 24 h.
The green cells with normal
morphology are viable ones
(AO?), while round red cells
are dead (PI?)
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